Clinical Trials Directory

Trials / Completed

CompletedNCT04267068

Single Session Intervention to Prevent Common Mental Disorders and Among College Students

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
375 (actual)
Sponsor
University of Nevada, Reno · Academic / Other
Sex
All
Age
17 Years – 26 Years
Healthy volunteers
Accepted

Summary

The present study aims to determine the effect of presenting psychoeducation emphasizing "growth-mindset," and information on depression and anxiety symptom severity. The investigators hypothesize that psychoeducation emphasizing that mental health is malleable will increase the participant's engagement with risk factors outlined in the intervention

Detailed description

Depression and anxiety disorders (or common mental disorders; CMDs) are increasingly common among college students, with rates comparable to the general population. As such, brief, scalable and transdiagnostic prevention efforts targeting CMDs are needed. In order to address this need, this study aims to evaluate the impact of a single session intervention (SSI) utilizing growth mindset (GM) on CMD symptom severity and investigate the mediating role of changes in modifiable risk factors in the relationship between intervention and CMD symptom reduction. The intervention will adapt existing GM interventions for college students to engage mechanisms in the prevention and management of common mental disorders including engagement in modifiable risk factors. College students will be randomly assigned to complete either a GM intervention or a psychoeducation control.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGrowth Mindset and Modifiable Risk Factor Information15 minute interactive article describing neuroplasticity followed by 15 minute interactive article describing modifiable risk factors for depression and anxiety
BEHAVIORALControl30 minute interactive article describing symptoms of depression and anxiety, common concerns of college student

Timeline

Start date
2019-08-05
Primary completion
2020-07-13
Completion
2020-07-13
First posted
2020-02-12
Last updated
2020-11-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04267068. Inclusion in this directory is not an endorsement.